Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.

Overview

authors

Collard, Harold R

Anstrom, Kevin J

Flaherty, Kevin R

Fleming, Thomas R

King, Talmadge E

Martinez, Fernando J
Brown, Kevin K

publication date

June 1, 2013

published in

American journal of respiratory and critical care medicine Journal

Research

keywords

Clinical Trials, Phase III as Topic
Endpoint Determination
Idiopathic Pulmonary Fibrosis
Respiratory System Agents

Identity

Scopus Document Identifier

84878976477

Digital Object Identifier (DOI)

10.1164/rccm.201304-0712LE

PubMed ID

23725623

Additional Document Info

volume

187

issue

11